Robert A Ritzel (Robert Ritzel)

Publication Activity (10 Years)

Years Active: 2017-2018
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Glycemic Control

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Robert A Ritzel, Stewart B Harris, Helen Baron, Hermes Florez, Ronan Roussel, Melanie Espinasse, Isabel Muehlen-Bartmer, Nianxian Zhang, Monica Bertolini, Claire Brulle-Wohlhueter, Medha Munshi, Geremia B Bolli
A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study. Diabetes care 41 (8) (2018)
Julio Rosenstock, Alice Cheng, Robert A Ritzel, Zsolt Bosnyak, Christine Devisme, Anna M G Cali, Jochen Sieber, Peter Stella, Xiangling Wang, Juan P Frías, Ronan Roussel, Geremia B Bolli
More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial. Diabetes care 41 (10) (2018)
Francisco Javier Escalada San Martín, Serge Halimi, Peter A Senior, Mireille Bonnemaire, Anna M G Cali, Lydie Melas-Melt, Janaka Karalliedde, Robert A Ritzel
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild-to-moderate renal impairment. Diabetes, obesity & metabolism 20 (12) (2018)
Robert A Ritzel, Ronan Roussel, Andrea Giaccari, Jiten Vora, Claire Brulle-Wohlhueter, Hannele Yki-Järvinen
Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes. Diabetes, obesity & metabolism 20 (3) (2017)